We bring you this week’s medtech news, from Boston and beyond:
1. Apple Watch modifies heart rate monitoring due to accuracy concerns
When Watch OS 1.0 debuted, the device recorded heart rate every 10 minutes but recently users have taken note (and Apple has confirmed) that’s no longer the case, Digital Trends reports. Achieving accuracy in heart rate monitoring technology as small as a watch is difficult. The change–less frequent readings when the whole body is in motion–aims to prevent erratic readings during exercise.
2. For teens, mom and dad know best in health but the Internet is a close second
A recent Northwestern University study found that 55 percent of adolescents reported their parents as a leading source of health information. Unsurprisingly, teens reported the Internet as their number one media source for health inquiries and nearly one-third of them used online research to adopt better health habits such as limiting soda intake, cooking healthier meals, and exercising to elevate mood.
3. FitBit updates IPO filing, set to raise $358 million
The personal fitness tracker FitBit has revealed new details ahead of its initial public offering, according to TechCrunch. The company, which has sold 20.8 million devices as of March 31 and raised $745.4 million in revenue last year, aims to sell about 22.4 million shares ($14 to $16 each). The IPO – trading as “FIT” – would bring in an estimated $358 million.
4. A Yelp for hospitals: AnalyticsMD launched this week
Curious how your institution stacks up against other hospitals nationwide? AnalyticsMD, a Yelp-like startup based in Palo Alto, Calif., foregoes patient testimonials and user reviews, instead crunching Center for Medicare & Medicaid Services data to award hospitals’ grades. “People can pull up the profile of most any hospital in the country to see its strengths, weaknesses, and overall grade. Most of the information is focused on three areas: the hospital’s emergency room, patient satisfaction, and in-patient cost efficiency,” reports Time.
5. Heart monitoring necklace receives FDA approval
ToSense, a San Diego startup, announced Wednesday it has received federal approval to launch its in-home heart monitoring necklace. The device, targeted at patients with chronic illnesses, “aims to detect signs of trouble up to two weeks earlier than current remote heart monitoring techniques – thus giving doctors time to take corrective measures” and reduce readmission rates, the San Diego Union-Tribune reports.
Paula is a freelance science writer and strategic communications associate at Health Leads. Formerly a managing editor at MedTech Boston, she has a B.S. in Journalism from Boston University and has worked with the New England Center for Investigative Reporting, Boston Globe, Social Documentary Network, BU Today and several nonprofit organizations. She can be reached at email@example.com.
Send this to a friend